Pear Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pear Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 202% to $12,694,000. Profit margin reached -187%. Total operating expenses were $127,862,000.
Profit Margin
| 2019 | 32.56M | 12.39M | 38.05% |
|---|---|---|---|
| 2020 | 9.38M | -100.58M | -1071.86% |
| 2021 | 4.20M | -20.29M | -482.27% |
| 2022 | 12.69M | -23.74M | -187.02% |
PEARW Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 12.69M | 4.20M | 9.38M | 32.56M |
Cost of revenue | 8.18M | 5.23M | 1.71M | 998K |
Gross profit | 4.51M | -1.02M | 7.66M | 31.56M |
Operating exp. | ||||
Research and development | 48.31M | 37.04M | 28.08M | 35.69M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 127.86M | 104.66M | 84.31M | 63.16M |
Operating income | -123.35M | -105.68M | -76.64M | -31.60M |
Other income (expenses), net | 47.85M | 40.54M | -12.16M | 22.26M |
Income before tax | -75.49M | -65.14M | -97.02M | -9.33M |
Income tax expense | -51.75M | -44.84M | 3.56M | -21.72M |
Net income | -23.74M | -20.29M | -100.58M | 12.39M |
Earnings per share | ||||
Basic EPS | -0.17 | -0.18 | -0.73 | 0.08 |
Diluted EPS | -0.17 | -0.18 | -0.73 | 0.08 |
| Data source | Data source |